FDA News

Certain prescription drugs may soon be available to consumers through digital kiosks, rather than a doctor's diagnosis, underscoring the methods technology is transforming healthcare.

Mobile devices increasingly diagnose and manage disease, putting them under the watchful eye of federal regulators, who could slow the pace of innovation.

The U.S. Food and Drug Administration is seeking a developer for a mobile alerts app that will communicate vital drug reaction information during public health crises.

The Food and Drug Administration on Tuesday released guidelines for medical apps, which could affect the speed of medical app development and the rate at which apps get into doctors' hands.

A blood pressure monitor, which plugs into an iPhone or iPad, recently received FDA approval, marking the expanding use of smartphones as health maintenance devices.

A new device transforms an iPhone into an electrocardiograph, in another medical innovation that changes conventional visits to the doctor as well as healthcare around the world.

Apple unveiled iCloud and iOS at its Worldwide Developers Conference. Meanwhile, Citigroup, Nintendo and Sony were all hacked, prompting governments around the world to continue their discussions on net neutrality.

Drug companies can now conduct product trials via smartphones and tablets, a development that, if successful, could lower prescription drug costs.

The Federal Drug Administration is making moves to regulate the growing number of mobile medical apps later this year, which could impact a growing market.

Microsoft surprised the industry by scooping up Skype, while AT&T defended its T-Mobile merger before Congress and Sony discovered yet another security breach.

Google may have to settle with the Justice Department for allowing merchants to advertising unlicensed drugs, adding to the company's growing list of legal woes.

The Food and Drug Administration is considering drafting guidelines to approve mobile health apps, prompting questions from medical experts and app makers how how this decision could impact this fast-growing market.